Concepedia

M Portier

MP

9

Publications

1.5K

Citations

9

H-Index

1991

Active since

Affiliations

Sanofi (France)(Current)

Inserm

Centre d'Immunologie et des Maladies Infectieuses

M Portier is an author at Sanofi (France) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1991–2001

9

Publications

9

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 704 citations · Full text

Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage

P Carayon, M Portier, D. Dussossoy et al. · Blood · 1996 · 184 citations · Full text

p53 and RAS gene mutations in multiple myeloma.

M Portier, Jean‐Pierre Molès, G R Mazars et al. · PubMed · 1992 · 151 citations

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

Bernard Klein, XG Zhang, M Jourdan et al. · PubMed · 1991 · 121 citations

, , +15

SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist

M Portier, M Rinaldi-Carmona, Florence Pecceu et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 104 citations

Rows per page

1–5 of 9